Table E3.
AEFI reported within 2 h of LAIV administration
| No. | Time to symptoms (min) | Description of events | IDMC review: possible allergic etiology? | Causality (due to LAIV) |
|---|---|---|---|---|
| 1 | 20-60 | Mild itchy facial rash; no recurrence with second dose of LAIV given 1 mo later | Yes | Unlikely |
| 2 | 5-20 | Mild generalized pruritus, no rash ?due to environmental exposure |
Yes | Possible |
| 3 | 5-20 | Itchy facial rash ?contact reaction from vaccine |
Yes | Probable |
| 4 | 20-60 | Rhinitis, facial hives, and mild angioedema. Possible causation due to exposure to a food allergen | Yes | Unlikely |
| 5 | 5-20 | Localized urticaria to nasal bridge and mild upper-lip swelling ?contact reaction from vaccine |
Yes | Probable |
| 6 | 5-20 | Nausea | No | |
| 7 | 5-20 | Itchy nose | No | |
| 8 | 20-60 | Occasional sniffing | No | |
| 9 | 20-60 | Generalized mild rash and itchy throat. No other symptoms. Frequently develops similar symptoms due to environmental exposure | Yes | Unlikely |
AEFI, Adverse event following immunization.